Today, the Alliance for Aging Research's Vice President of Public Policy Cynthia Bens testifed before the U.S. House of Representatives' Energy and Commerce Committee, Subcommittee on Health, in regard to reauthorization of the Medical Device User Fee Act (MDUFA).
Alliance for Aging Research Vice President of Public Policy Cynthia Bens issued the following statement regarding congressional action taken this week to begin consideration of the U.S. Food and Drug Administration’s (FDA) prescription drug and medical device user fee programs.
The Alliance for Aging Research is partnering with Relevate Health Group® to raise awareness about deep vein thrombosis (DVT) and venous thromboembolism (VTE) in honor of Deep Vein Thrombosis Awareness Month in March and World Thrombosis Day on October 13.
Alliance for Aging Research (Alliance) President and CEO Susan Peschin, MHS, has issued a statement regarding the markup of the American Health Care Act by the Committee on Ways and Means and the Energy and Commerce Committee in the U.S. House of Representatives.
The first-ever National Heart Valve Disease Awareness Day is being celebrated throughout the country today, as organizations, advocates, and individuals join together to increase recognition about the risks of heart valve disease (HVD) and improve detection and treatment access to ultimately save lives.
The Alliance has joined with more than 90 national organizations in urging the Senate to ensure Secretary of HHS nominee Tom Price, M.D., is committed to protecting U.S. citizens from vaccine preventable diseases.
Today, the Alliance for Aging Research (Alliance) announced that February 22, 2017, will serve as the first-ever National Heart Valve Disease Awareness Day, with annual observances to follow. In addition, the U.S. Department of Health and Human Services (HHS) has listed this new awareness day and an accompanying toolkit on its National Health Observances Calendar (NHO).
The Aging in Motion (AIM) Coalition hosted its second annual meeting with U.S. Food and Drug Administration (FDA) leaders and leading scientists, industry representatives, and advocates to discuss developments and advances in clinical research and treatment of sarcopenia in Bethesda, Md.
Today, senior representatives from the U.S. Food and Drug Administration (FDA) and the National Institute on Aging at the National Institutes of Health (NIH) joined with advocates, federal colleagues, researchers, and industry to explore collaborations for advancing the most up-to-date knowledge in Alzheimer’s disease research.
Sign up for our email newsletter, Living Longer & Loving It, for the latest information on scientific research on aging and health.